Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

Glenda Gray, program director of a research consortium, talked with STAT about the impact of the funding freeze on an HIV ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

Understanding how ... A Chain Reaction: HIV Vaccines Can Lead to Antibodies Against Antibodies Jan. 17, 2025 — Many vaccines work by introducing a protein to the body that resembles part of a virus.